A team led by Wan, Wan, and Liu published a study in npj Parkinson’s Disease in 2026 on a detection pipeline using non-contact, multi-modality measurements paired with artificial intelligence to catch early-stage Parkinson’s disease before symptoms become clinically obvious. The approach extracts subtle physiological and behavioral signals without physical sensors, reducing friction for large-scale screening. The core model learns from multiple data streams simultaneously, aligning complementary signals to capture patterns reflecting dopaminergic dysfunction, altered movement dynamics, and systemic changes, then fuses them into a unified prediction space. The authors report an architecture optimized to maintain performance while minimizing computation, enabling faster inference for clinical or at-home workflows. The model leverages deep learning for feature extraction and multi-modal fusion, with training tailored to improve generalization across individuals and measurement conditions. The study frames non-contact measurement as a safety and comfort advantage, lowering contamination risks and supporting longitudinal monitoring. Reported results suggest the AI system can discriminate early-stage Parkinson’s signatures more effectively than approaches using fewer measurement channels.